Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.280
-0.030 (-2.29%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $106.17 million as of December 20, 2024. Its market cap has increased by 70.80% in one year.
Market Cap
106.17M
Enterprise Value
95.24M
1-Year Change
70.80%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $106.17M, an increase of 52.18%. That is a compound annual growth rate of 7.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 109.78M |
| Eupraxia Pharmaceuticals | 108.94M |
| Acumen Pharmaceuticals | 108.14M |
| MultiPlan | 107.86M |
| Protara Therapeutics | 106.86M |
| Tonix Pharmaceuticals Holding | 106.53M |
| Leap Therapeutics | 106.52M |
| MediciNova | 105.94M |